approved EB-2 (NIW)

Senior Researcher

Materials Science And Engineering · Pakistan · 2025-03-12

Processing Time
293 days
Decision Date
2025-03-12
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to identify ideal materials for biomedical applications and develop innovative cancer drugs. The work focuses on enhancing the quality and accessibility of medical treatments through advancements in artificial heart valves, dental implants, and joint replacements. The research aims to improve patient outcomes and enhance the safety and stability of medical implants.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical national healthcare challenges including cancer therapies and medical implant safety.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., 11 publications, and 139 citations demonstrate they are exceptionally well-positioned.

3 Balance of Interests Met

The petitioner's record of achievement and the importance of their research to U.S. technological leadership justify a waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in materials science and a record of 11 peer-reviewed journal articles. The research influence was evidenced by 139 citations and participation in at least two peer reviews for notable journals. Additionally, the work received funding from major institutions like the National Research Foundation of Korea and aligned with U.S. National Science and Technology Council priorities.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Government Alignment

Similar Cases

Engineer

Materials Science · China

WeGreened EB-2 (NIW) approved
California 6 days 2023-08-02
The petitioner proposes to investigate the biomedical applications of advanced biomaterials and manufacturing technologies to develop tissue substitutes for regenerative medicine. This work aims to create tumor models for cancer study to improve the outcomes of preclinical trials, diagnosis, and treatment.

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Michigan 655 days 2025-08-08
The petitioner proposes to develop new material characterization techniques to synthesize and describe novel materials for use in biomaterials and therapeutics. Her work focuses on innovative nanocomposite synthesis with large surface area and biocompatibility for drug delivery, wound healing, and anti-pathogen coatings. Additionally, she aims to study novel chemical derivatives to lay the groundwork for future treatments for Alzheimer’s disease.

Others

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 289 days 2025-02-28
The petitioner proposes to design novel biomaterials and wearable devices to advance personalized healthcare through continuous monitoring and early detection of chronic conditions. His work involves developing nanostructured materials for targeted drug delivery and tissue engineering, as well as creating flexible devices capable of capturing physiological signals for diagnosis.

Research Scientist

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
Washington 117 days 2023-02-01
The petitioner proposes to design technological infrastructure for new, cost-effective, industry-grade tools that interface with and house human tissue. This work focuses on advancing the development of novel disease treatments and vaccines by modeling human tissues and their response to vaccination agents.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 293 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist